Scientists discover an unexpected way to make pancreatic cancer cells self-destruct
Researchers at Florida A&M University have identified a compound, NSL-YHJ-2-27, that effectively inhibits the migration and viability of pancreatic cancer cells. This study suggests a potential new therapeutic pathway for treating aggressive, KRAS-mutated pancreatic cancers.
Why it matters
Pancreatic cancer remains one of the most lethal forms of cancer, and this discovery offers a potential new mechanism to prevent metastasis and tumor growth.
A study published in Oncotarget is highlighting a promising new approach to fighting pancreatic cancer. The paper, titled "The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation," was led by first author Kweku Ofosu-Asante and corresponding author Nazarius S. Lamango of the Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health in Tallahassee, Florida.
The article summarizes scientific research findings objectively without editorializing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in